Author:
Lortie Andreanne,Martin Elizabeth A.,Arnot Kate
Subject
Toxicology,General Medicine
Reference12 articles.
1. Calculating qualified non-mutagenic impurity levels: Harmonization of approaches;Graham;Regul. Toxicol. Pharmacol.,2021
2. Management of organic impurities in small molecule medicinal products: deriving safe limits for use in early development;Harvey;Regul. Toxicol. Pharmacol.,2017
3. ICH M3 (R2) on Non-clinical Safety Studies for the Conduct of Human Clinical Trials and Marketing Authorisation for Pharmaceuticals,2009
4. Assessment and Control of DNA Reactive (Mutagenic) Impurities in Pharmaceuticals to Limit Potential Carcinogen Risk,2023
5. ICH Q3A (R2) on Impurities in New Drug Substances,2006
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献